药品首页 >
日本直供
专病产品 > 帕金森

NOURIAST 伊曲茶碱片

通用名称伊曲茶碱片 Istradefylline
品牌名称NOURIAST
产地|公司日本(Japan) | 协和发酵麒麟(Kyowa Hakko Kirin)
技术状态原研产品
成分|含量20mg
包装|存储30片/盒 室温
微信客服
Xirou_Canada
微信ID
(8:00-15:00)
服务时间
通用中文 伊曲茶碱片 通用外文 Istradefylline
品牌中文 品牌外文 NOURIAST
其他名称
公司 协和发酵麒麟(Kyowa Hakko Kirin) 产地 日本(Japan)
含量 20mg 包装 30片/盒
剂型给药 片剂口服 储存 室温
适用范围
通用中文 伊曲茶碱片
通用外文 Istradefylline
品牌中文
品牌外文 NOURIAST
其他名称
公司 协和发酵麒麟(Kyowa Hakko Kirin)
产地 日本(Japan)
含量 20mg
包装 30片/盒
剂型给药 片剂口服
储存 室温
适用范围

使用说明书

(免责声明:本说明书仅供参考,不作为治疗的依据,不可取代任何医生、药剂师等专业性的指导。本站不提供治疗建议,药物是否适合您,请专业医生(或药剂师)决定。)
等待内容更新

中文说明

(免责声明:本说明书仅供参考,不作为治疗的依据,不可取代任何医生、药剂师等专业性的指导。本站不提供治疗建议,药物是否适合您,请专业医生(或药剂师)决定。)

部份中文伊曲茶碱处方资料(仅供参考)
商品名:NOURIAST
英文名:Istradefylline
中文名:伊曲茶碱片
生产商:协和发酵麒麟制药
药品简介
伊曲茶碱(istradefylline,KW6002)是由日本协和发酵株式会社研发,于2013年3月在日本上市,2013年已向FDA提交申请。伊曲茶碱(Istradefylline)是一种新的A2A受体拮抗剂,能明显缩短关期,延长开期,且耐受性和安全性良好。临床试验结果显示可显著降低左旋多巴治疗的剂末现象。
它可单纯用于治疗早期PD症状,也可治疗PD患者的精神症状,如焦虑、抑郁等,还能逆转抗精神病药物引起的木僵。
伊曲茶碱(istradefylline,KW6002)是选择性的腺苷A2受体拮抗剂,能通过改变神经元的活动而改善PD患者的运动机能,临床用于治疗PD和改善PD初期的运动障碍。在凌长类动物帕金森病模型中,本品可改善其运动不能症状。
ノウリアスト錠20mg
药物类别名称
腺苷 A2A 受体拮抗剂
批准日期:2013年5月
欧文商標名
NOURIAST Tablets
一般名
イストラデフィリン Istradefylline
化学名
(E)-8-(3, 4-Dimethoxystyryl)-1, 3-diethyl-7-methyl-3, 7-dihydro-1H -purine-2, 6-dione
分子式
C20H24N4O4=384.43
化学構造式
性状
它是一种浅黄绿色的结晶粉末。
熔点
192.9
分布系数
日志P_OCT=3.5
(测量方法:发拉斯克摇动法)
n-辛醇/pH7.0缓冲液)
处理注意事项
此剂涂有薄膜,以确保光稳定性,因此请勿通过研磨使用。
药用药理学
该剂是腺苷A2A受体拮抗剂,通过阻断纹状体和淡蓝色球中的受体来表达对帕金森病的治疗效果。
(1)药理作用
1)该剂改善卡塔普反应是治疗小鼠的运动障碍。当与这种代理左旋多巴结合使用时, 卡塔莱普改善效果增强.
2) 此剂增加帕金森氏病模型1-甲基-4-苯基-1,2,3,6四氢丙氨酸 (MPTP) 治疗马莫塞特的自发动量,并改善运动功能障碍。当该剂与左旋多巴结合使用时,左旋多巴的作用增强,左旋多巴的作用持续时间延长。
3) 本剂不影响MPTP治疗马莫塞特的左旋多巴的非自愿运动强度。
(2) 行动机制
1)本剂用于人体重组腺苷A2AAA受体,但表现出高亲和力,亲和力为人体重组腺苷A1,A3受体低(体外)。
2) 本剂通过腺苷A2A激动剂CGS21680在PC-12细胞(体外)抑制cAMP积累增加作用。
3)在黑色纹状体单侧破坏大鼠是帕金森氏病模型大鼠,降低淡蓝色球伽马氨基丁酸(GABA)细胞外浓度增加。
适应病
帕金森病治疗中含左旋多巴制剂的磨损现象的改善
用法与用量
该剂与含左旋多巴的配方结合使用。 通常,成人口服一次,每天20毫克,如伊斯特拉多林。另外, 它可以口服一次,每天 40 毫克取决于症状.
包装规格
片剂 20 毫克:
[PTP] 30片(10 片×3),100片(10片×10)
制造和销售
协和发酵麒麟制药

 

 

 

 

 

 

 

 

 

 

 

外文说明

(免责声明:本说明书仅供参考,不作为治疗的依据,不可取代任何医生、药剂师等专业性的指导。本站不提供治疗建议,药物是否适合您,请专业医生(或药剂师)决定。)

Description

This medicine weakens the action of adenosine, a neurotransmitter in the brain, and consequently improves wearing-off phenomenon (a state of the onset of parkinsonian symptoms) caused by the decreased effects of other concomitant antiparkinsonian medicines resulting from their long-term use.
It is usually used to improve wearing-off phenomenon in patients with Parkinson’s disease on the treatment with levodopa-containing products.

Presentation

30 tablets

Feature

yellowish brown tablet, diameter 7.1 mm, thickness 3.3 mm

Active Ingredients

Istradefylline 20mg

Effect/Efficacy

This medicine weakens the action of adenosine, a neurotransmitter in the brain, and consequently improves "wearing-off" phenomenon (a state of the onset of parkinsonian symptoms) caused by the decreased effects of other concomitant antiparkinsonian medicines resulting from their long-term use.
It is usually used to improve wearing-off phenomenon in patients with Parkinson’s disease on the treatment with levodopa-containing products.

Usage/Dosage

In general, for adults, take 1 tablet (20mg of the active ingredient) at a time, once a day, in conjunction with levodopa-containing products. Depending on your symptoms, the dose may be increased up to 2 tablets (40mg) at a time. Strictly follow the instructions.
If you missed a dose, take a dose as soon as possible. However, if it is almost time for the next dose, skip the missed dose and follow your regular dosing schedule. You should never take two doses at one time.
If you accidentally take more than your prescribed dose, consult with your doctor or pharmacist.
Do not stop taking this medicine unless your doctor instructs you to do so.

Cautions

In general, for adults, take 1 tablet (20mg of the active ingredient) at a time, once a day, in conjunction with levodopa-containing products. Depending on your symptoms, the dose may be increased up to 2 tablets (40mg) at a time. Strictly follow the instructions.

If you missed a dose, take a dose as soon as possible. However, if it is almost time for the next dose, skip the missed dose and follow your regular dosing schedule. You should never take two doses at one time.

If you accidentally take more than your prescribed dose, consult with your doctor or pharmacist.

Do not stop taking this medicine unless your doctor instructs you to do so.

Precautions while taking this medicine
This medicine may cause sudden onset of sleep and somnolence (falling into a half-doze) without any signs, orthostatic hypotension (dizziness on standing up), dizziness, loss of consciousness, and syncope. Avoid engaging in dangerous activities, such as driving a car, operating machinery, or working at heights.
If shortness of breath, breathlessness, or dry cough without phlegm occurs, consult with your doctor or pharmacist.
Note that smoking may weaken the action of the medicine.


Possible adverse reactions to this medicine

"The most commonly reported adverse reactions include dyskinesia (involuntary movement), constipation, visual hallucination or hallucination (seeing things or hearing sound that do/dose not actually exist), somnolence, nausea, and weight decreased. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.

- seeing things or hearing sound that do/does not actually exist, groundless belief in something untrue [visual hallucination, hallucination, auditory hallucination, somatic hallucination, delusion, persecutory delusion]
- disturbed consciousness [delirium]
- vague sense of fear [anxiety disorder]
- having no energy, being depressed, loss of sleep [aggravation of depression/depression]
- elation, excitement, being overexcited [mania, agitation]
- uncontrollable craving/desire [impulse-control disorder]

The above symptoms do not describe all the adverse reactions to this medicine.

Contraindication

The most commonly reported adverse reactions include dyskinesia (involuntary movement), constipation, visual hallucination or hallucination (seeing things or hearing sound that do/dose not actually exist), somnolence, nausea, and weight decreased. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
seeing things or hearing sound that do/does not actually exist, groundless belief in something untrue [visual hallucination, hallucination, auditory hallucination, somatic hallucination, delusion, persecutory delusion]
disturbed consciousness [delirium]
vague sense of fear [anxiety disorder]
having no energy, being depressed, loss of sleep [aggravation of depression/depression]
elation, excitement, being overexcited [mania, agitation]
uncontrollable craving/desire [impulse-control disorder]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.